2GISSI investigators.Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction.
3USUS-2 Collaborative group.Randomized trial of intravenous streptokinase,oral aspirin,both,or neither among 17187 cases of suspected acute myocardial infarction:ISIS-2 Lancet,1988;Ⅱ:349.
4The TIMI Ⅲ A investigators.Early effects of tissue-type plasminogen activator added to convention therapy on the culprit coronary lesion in patients presenting with ischemic cardiac pain at rest.Results of the thrombolysis in myocardial ischemia(TIMI II A) trial. Circulation, 1993;87:38.
5The TIMI ⅢB investigators.Effects of tissue plasminogen.activator and a comparison of early invasive and conservative strategies in umtable angina and non-Q wave myocardial infarction.Results of the TIMI ⅢB trial Circulation, 1994;89:1545.
6The Scandinavian Simvastatin Survival Study Guoup.Randomized trial of cholesterol lowering in 4444 patients with coronary heart disesse:the Scandinavian Simvastatin Survival Study(4S).Lancet,1994;344:1383.
7Sacks FM, Pfeffer MA, Moye LA,et al.The effect of pravastatin on coronary events after myocardial irfarction in patients with average cholesterol levels.N Engl J Med,1996;335:1001.
8The LIPID Study group. Design features and baseline characteristics of the LIPID Study:a randomized trial in Patients with previous acute myocardial infarction and/or unstable angina pectoris.Am J Cardiol, 1995;76:474.
9Amiodarone Trial Meta-Analysis Investigators.Effect of prophylactic amiodarone on motality after acute myocardial infarction and in congestive heart failure:meta-analysis of individual data from 6500 patients in randomized trials.Lancet,1997;35):1417.
10Chinese Cardiac Study Collaborative Group.Oral captopil versus placebo among 13 634 patients with suspected acute myocardial infarction:interim report from the Chinese Cardiac Study(CCS-1).Iancet,1995;345:686.
